Novo Nordisk Buys Hypertension Drug Ocedurenone For $1.3 Billion—Expanding Ozempic Maker’s Arsenal

México Noticias Noticias

Novo Nordisk Buys Hypertension Drug Ocedurenone For $1.3 Billion—Expanding Ozempic Maker’s Arsenal
México Últimas Noticias,México Titulares
  • 📰 Forbes
  • ⏱ Reading Time:
  • 30 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 15%
  • Publisher: 53%

I cover breaking news for Forbes. Before Forbes, I worked as a reporter for USA Today in Asheville and Black Mountain, North Carolina.

Novo Nordisk—manufacturer of popular diabetes and weight-loss drugs Ozempic and Wegovy—will acquire the drug ocedurenone for $1.3 billion, an experimental drug the Danish firm says could be used to treat uncontrolled hypertension, with potential applications for treating cardiovascular and kidney disease.

Ocedurenone is an orally administered drug that works against aldosterone, a hormone that raises your body’s blood pressure. The drug is still in late-stage testing for treating uncontrolled hypertension—a condition in which blood pressure is high despite multiple treatments—and was previously investigated in nine other clinical trials, including one whichNovo Nordisk said it will launch other late-stage trials for the drug to test ocedurenone’s effectiveness for cardiovascular and kidney disease “in the coming years” in an effort to “maximize the full potential” of the drug.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

Forbes /  🏆 394. in US

México Últimas Noticias, México Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

Novo Nordisk to buy hypertension treatment from for $1.3 billion from KBP BiosciencesNovo Nordisk to buy hypertension treatment from for $1.3 billion from KBP BiosciencesTomi Kilgore is MarketWatch's deputy investing and corporate news editor and is based in New York. You can follow him on Twitter TomiKilgore.
Leer más »

‘Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdles‘Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdlesTwo experts see major challenges facing the adoption of Novo Nordisk and Eli Lilly’s obesity drugs.
Leer más »

'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdles'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdlesTwo experts see major challenges facing the adoption of Novo Nordisk and Eli Lilly's obesity drugs.
Leer más »

Ravens' Lamar Jackson buys time, finds Zay Flowers for first TDRavens' Lamar Jackson buys time, finds Zay Flowers for first TDAfter four field goals, Baltimore's quarterback was able to get the game's first TD in London against the Tennessee Titans.
Leer más »

AITA: Person Buys Cake That A Child WantedAITA: Person Buys Cake That A Child Wanted'When the worker took it out for me, the girl started screaming and crying. The mother did initially ask if I could leave the roll for her, but I said that I ordered first.'
Leer más »

‘Three’s Company’ Star Suzanne Somers Dies At 76: Here Are The Biggest Celebrity Deaths Of 2023‘Three’s Company’ Star Suzanne Somers Dies At 76: Here Are The Biggest Celebrity Deaths Of 2023I'm an explainers and trends reporter for Forbes. I previously worked on Forbes's wealth team where I covered billionaires. I graduated from the University of Pennsylvania in 2022 and spent that summer working on Forbes's Top Colleges list.
Leer más »



Render Time: 2025-02-28 09:55:35